Summary of New Research Funded in 2009
Institution and Investigator |
Years |
Project Title |
Direct Costs |
Indirect Costs |
Total Cost |
|
Beckman Research Institute of the City of Hope |
||||||
|
Kimlin Ashing-Giwa |
1 |
Sister Survivor: Evaluating Best Practices in Social Support |
$5,000 |
$0 |
$5,000 |
This is a collaborative planning grant with Carolyn Tapp of Women of Color Breast Cancer Survivors Support Project |
||||||
A* |
Leslie Bernstein |
1 |
Woman Care Study |
$19,917 |
$13,145 |
$33,062 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
|
Hei Chan |
2 |
The Role of Estrogen Receptor in Endocrine Resistance |
$76,000 |
$0 |
$76,000 |
|
Katherine DeLellis-Henderson |
1 |
California Teachers’ Study |
$19,853 |
$13,103 |
$32,956 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
T* |
Yani Lu |
2 |
Risk Factors and Breast Cancer Survival in Black/White Women |
$89,996 |
$0 |
$89,996 |
|
Sumanta Pal |
1.5 |
Survival in de novo and Recurrent Metastatic Breast Cancer |
$150,000 |
$99,000 |
$249,000 |
Circulo de Vida Cancer Support and Resource Center |
||||||
|
Carmen Ortiz |
3 |
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
$250,453 |
$62,614 |
$313,067 |
This is a collaborative grant with Anna Napoles-Springer of University of California, San Francisco. |
||||||
Dr. Susan Love Research Foundation |
||||||
|
Dixie Mills |
1 |
6th Symposium on the Intraductal Approach to Breast Cancer |
$25,000 |
$0 |
$25,000 |
Kaiser Foundation Research Institute |
||||||
|
Lawrence Kushi |
1 |
Mammary Gland Evaluation and Risk Assessment |
$25,000 |
$0 |
$25,000 |
|
Marilyn Kwan |
1.5 |
Patient and Clinician Knowledge of Breast Cancer Lymphedema |
$149,989 |
$77,795 |
$227,784 |
|
Marilyn Kwan |
1 |
Pathways: A Study of Breast Cancer Survivorship and Life after Cancer Epidemiology (LACE) Study |
$19,952 |
$10,528 |
$30,480 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
Lawrence Berkeley National Laboratory |
||||||
|
Laurie Friesenhahn |
2 |
The Regulation of SATB1 in Metastatic Breast Cancer |
$90,000 |
$0 |
$90,000 |
|
Trent Northen |
1.5 |
Metabolite Imaging to Identify Drug Resistant Breast Cancer |
$99,133 |
$73,104 |
$172,237 |
|
Daojing Wang |
1.5 |
Role of p68 in Breast Cancer |
$100,000 |
$65,339 |
$165,339 |
Northern California Cancer Center |
||||||
|
Scarlett Gomez |
2 |
Demographic Questions for California BC Research-Gomez |
$299,994 |
$130,994 |
$430,988 |
A* |
Susan Hurley & Peggy Reynolds |
1 |
Exploring Disparities Environmental Risk Factors in Teachers |
$99,851 |
$32,352 |
$132,203 |
|
Esther John |
1 |
San Francisco Bay Area Breast Cancer Study |
$20,000 |
$9,000 |
$29,000 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
|
David Nelson |
2 |
Model-building with Complex Environmental Exposures |
$191,858 |
$86,337 |
$278,195 |
Palo Alto Institute for Research & Education |
||||||
|
Russell Pachynski |
2 |
Chemerin as an Immunotherapeutic Agent in Breast Cancer |
$90,000 |
$0 |
$90,000 |
|
Robert West |
2 |
Stroma Expression Patterns in Breast Cancer |
$250,000 |
$102,500 |
$352,500 |
Public Health Institute |
||||||
|
Barbara Cohn |
5 |
Environmental Causes of Breast Cancer Across Generations |
$4,564,314 |
$435,686 |
$5,000,000 |
|
Eric Roberts |
2 |
Cancer Mapping: Making Spatial Models Work for Communities |
$299,887 |
$49,338 |
$349,225 |
Salk Institute for Biological Studies |
||||||
|
Dannielle Engle |
2 |
A Genetic System for Identification of Mammary Stem Cells |
$76,000 |
$0 |
$76,000 |
Scripps Research Institute |
||||||
|
Melissa Dix |
2 |
Substrate Profiling of Breast Cancer Related Proteases |
$76,000 |
$0 |
$76,000 |
|
Brunhilde Felding-Habermann |
1.5 |
Combating Breast Cancer with the Wellderly Immune Repertoire |
$150,000 |
$134,850 |
$284,850 |
T* |
Karin Staflin |
2 |
P32: New Functional Target in Breast Cancer Brain Metastasis |
$90,000 |
$0 |
$90,000 |
|
Xiaohua Wu |
1.5 |
Targeting DNA Repair Function of Breast Cancer Stem Cells |
$150,000 |
$134,850 |
$284,850 |
Stanford University |
||||||
|
Margaret Fuller |
1.5 |
Novel Tumor Suppressors in Breast Development and Cancer |
$150,000 |
$81,058 |
$231,058 |
|
Jonathan Pollack |
1.5 |
Discovery of Fusion Genes in Breast Cancer |
$100,000 |
$60,000 |
$160,000 |
|
Albert Wong |
1.5 |
The Role of EGF Variant mLEEK and Grp78 in Breast Cancer |
$150,000 |
$91,380 |
$241,380 |
The Burnham Institute for Medical Research |
||||||
|
Sonia del Rincon |
1.5 |
Finding BRCA1 Ubiquitinated Substrates in Breast Cancer |
$100,000 |
$91,000 |
$191,000 |
|
Adam Richardson |
1.5 |
Proline Metabolism in Metastatic Breast Cancer |
$149,160 |
$135,735 |
$284,895 |
University of California, Berkeley |
||||||
|
John Balmes |
1 |
California Chemicals Policy & Breast Cancer |
$159,334 |
$0 |
$159,334 |
University of California, Davis |
||||||
|
Steven Chen |
1.5 |
Reducing Surgical Morbidity of Breast Cancer Staging |
$149,983 |
$0 |
$149,983 |
|
Damon Meyer |
2 |
Control of BRCA2-mediated Homologous Recombination |
$90,000 |
$0 |
$90,000 |
University of California, Irvine |
||||||
|
Kyoko Yokomori |
1.5 |
Inhibitors of Condensin I as Chemotherapy for Breast Cancer |
$100,000 |
$0 |
$100,000 |
University of California, Los Angeles |
||||||
T* |
Arash Naeim |
1.5 |
Health Literacy in Older Patient's Breast Cancer Treatment |
$180,890 |
$0 |
$180,890 |
|
Frank Pajonk |
2 |
Modulation of Breast Cancer Stem Cell Response to Radiation |
$250,000 |
$0 |
$250,000 |
|
Richard Pietras |
1.5 |
Membrane-associated Estrogen Receptors in Breast Cancer |
$150,000 |
$0 |
$150,000 |
University of California, San Diego |
||||||
|
Jakob Nebeker |
2 |
Sound Speed Tomography for Early Breast Cancer Detection |
$74,392 |
$0 |
$74,392 |
|
Michelle Rissling |
2 |
Health Anxiety as a Risk for Insomnia in Breast Cancer |
$73,855 |
$0 |
$73,855 |
University of California, San Francisco |
||||||
|
Cindy Benod |
2 |
Compounds Blocking Assembly of LRH-1 in Breast Cancer |
$90,000 |
$0 |
$90,000 |
|
Frances Brodsky |
1.5 |
A Molecular Strategy to Inhibit Breast Cancer Metastasis |
$150,000 |
$0 |
$150,000 |
|
Jonathan Chou |
2 |
Understanding the Role of GATA3 in Breast Cancer |
$76,000 |
$0 |
$76,000 |
|
Robert Hiatt |
1 |
New Paradigm of Breast Cancer Causation and Prevention |
$229,732 |
$0 |
$229,732 |
|
Dai Horiuchi |
2 |
Targeting MYC in Human Breast Cancer |
$90,000 |
$0 |
$90,000 |
|
Kuang-Yu Jen |
2 |
Role of Circadian Rhythm Gene Homolog PER3 in Breast Cancer |
$90,000 |
$0 |
$90,000 |
|
Celia Kaplan |
3 |
Breast Cancer Risk Reduction: A Patient-Doctor Intervention |
$740,690 |
$0 |
$740,690 |
|
Rita Mukhtar |
2 |
Macrophages in Breast Cancer Patients of African Descent |
$90,000 |
$0 |
$90,000 |
|
Anna Napoles-Springer |
3 |
Nuevo Amanecer: Promoting the Psychosocial Health of Latinas |
$349,547 |
$0 |
$349,547 |
This is a collaborative grant with Carmen Ortiz of Circulo de Vida Cancer Support and Resource Center. |
||||||
|
Lisa Singer |
2 |
Diffusion-Weighted MRI in Monitoring Breast Cancer Treatment |
$76,000 |
$0 |
$76,000 |
University of California, Santa Barbara |
||||||
|
Claudia Gottstein |
1.5 |
Antibody-based Targeting of Breast Cancer Stem Cells |
$150,000 |
$0 |
$150,000 |
|
Jennifer Smith |
2 |
A Predictive Factor for Eribulin Treatment of Breast Cancer |
$76,000 |
$0 |
$76,000 |
University of Southern California |
||||||
|
Graham Casey |
1.5 |
Podocalyxin as a Basal-like Breast Cancer Stem Cell Marker |
$149,911 |
$93,765 |
$243,676 |
|
Kristine Monroe |
1 |
Multiethnic Cohort Study |
$19,045 |
$11,998 |
$31,043 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
|
Daniel Stram |
2 |
New Methods for Genomic Studies in African American Women |
$276,588 |
$166,043 |
$442,631 |
|
Anna Wu |
3 |
Soy Treatment for High-risk Women and DCIS Patients |
$750,000 |
$467,500 |
$1,217,500 |
|
Anna Wu |
1 |
Los Angeles County Asian American Breast Cancer Study |
$103,000 |
$63,000 |
$166,000 |
This is a sub-award of the SRI initiative, “Understanding Racial and Ethnic Differences in Stage-specific Breast Cancer Survival: A Pilot Study” |
||||||
Vaccine Research Institute of San Diego |
||||||
|
Per Borgstrom |
1.5 |
Breast Cancer Tumor-Stroma Interactions in an In Vivo Model |
$150,000 |
$134,250 |
$284,250 |
Women of Color Breast Cancer Survivors Support Project |
||||||
|
Carolyn Tapp |
1 |
Sister Survivor: Evaluating Best Practices in Social Support |
$5,000 |
$0 |
$5,000 |
This is a collaborative planning grant with Kimlin Ashing-Giwa of Beckman Research Institute of the City of Hope. |
||||||
Totals |
|
$13,017,324 |
$2,926,264 |
$15,943,588 |
||
|
||||||
T* |
Funded in part by Tax Check-off voluntary contributions from individual taxpayer's income tax forms. |
|||||
A* |
Funded in part by a grant from the Avon Foundation for Women. |
|||||
